New drug combo aims to fight lung cancer after first treatment fails

NCT ID NCT06841055

Recruiting now Disease control Sponsor: BioNTech SE Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new drug called pumitamig (BNT327) combined with standard chemotherapy (docetaxel) in 60 people with advanced non-small cell lung cancer that got worse after initial treatment. The goal is to see if the combination is safe and shrinks tumors. It is an early-phase, open-label trial currently recruiting participants.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: pumitamig (also called BNT327, PM8002, or BMS-986545) combined with docetaxel chemotherapy
What this could lead to: If successful, this could offer a new treatment option for people with advanced lung cancer whose first therapy stopped working.
What could go wrong: This is an early Phase 2 trial with only 60 participants, so results may not apply to everyone. The combination may cause side effects like infusion reactions or immune-related issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NON-SMALL CELL LUNG CANCER

Contacts and locations

Locations

Ankara Bilkent City Hospital
RECRUITING

Ankara, 06800, Turkey (Türkiye)
Baptist Health Hardin
RECRUITING

Elizabethtown, Kentucky, 42701, United States
Baskent University Adana Turgut Noyan Application and Research Center Kisla Health Campus
RECRUITING

Adana, 01250, Turkey (Türkiye)
Cancer Research SA (CRSA)
RECRUITING

Adelaide, South Austraila, 5000, Australia
Chungbuk National University Hospital
RECRUITING

Cheongju-si, 28644, South Korea
Gachon University Gil Medical Center
RECRUITING

Incheon, 21565, South Korea
Gyeongsang National University Hospital (GNUH)
RECRUITING

Jinju, Gyeongsangnam-do, 52727, South Korea
Hobart Hospital-Royal Hobart Hospital
RECRUITING

Hobart, Tasmania, 7000, Australia
Hospital Universitario Fundacion Jimenez Diaz
RECRUITING

Madrid, 28040, Spain
Hospital Universitario Ramón y Cajal
RECRUITING

Madrid, 28034, Spain
Hospital Universitario Virgen del Rocio
RECRUITING

Seville, 41013, Spain
Institut dInvestigacio Biomedica de Bellvitge (IDIBELL)
RECRUITING

Barcelona, 08908, Spain
Koc Universitesi Hastanesi (Koc University Hospital)
RECRUITING

Zeytinburnu, 34010, Turkey (Türkiye)
Liverpool Cancer Therapy Centre
RECRUITING

Liverpool, New South Wales, 2170, Australia
Memorial Ankara Hospital
RECRUITING

Ankara, 06520, Turkey (Türkiye)
Memorial Antalya Hospital
RECRUITING

Antalya, 07090, Turkey (Türkiye)
Metro South Health - Princess Alexandra Hospital (PAH)
RECRUITING

Woolloongabba, Queensland, 4102, Australia
Moffitt Cancer Center
RECRUITING

Tampa, Florida, 33612, United States
NYU Langone - NYU Grossman School of Medicine
RECRUITING

New York, New York, 10016, United States
One Clinical Research - Hollywood Private Hospital
RECRUITING

Nedlands, Western Australia, 6009, Australia
Samsung Medical Center
RECRUITING

Seoul, 06351, South Korea
Sarah Cannon Research Institute
RECRUITING

London, W1G 6AD, United Kingdom
Severance Hospital, Yonsei University Health System
RECRUITING

Seoul, 03722, South Korea
St James's University Hospital - Leeds Teaching Hospitals NHS Trust
RECRUITING

Leeds, LS9 7TF, United Kingdom
Texas Oncology, P.A.
COMPLETED

Houston, Texas, 77090, United States
The Christie NHS Foundation Trust
RECRUITING

Manchester, M20 4BX, United Kingdom
The University of Alabama at Birmingham Hospital
RECRUITING

Birmingham, Alabama, 35249, United States
Universitat de Valencia - Hospital Universitari i Politecnic La Fe de Valencia (Hospital La Fe Bulevar Sur)
RECRUITING

Valencia, 46026, Spain
Velindre NHS Trust, Velindre Cancer Centre
RECRUITING

Cardiff, CF14 2TL, United Kingdom
Yeditepe University Hospital
RECRUITING

Istanbul, 34752, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.